New device aims to deliver healing cells to spinal cord injuries
Disease control
Recruiting now
This early-stage study tests a new device that delivers special cells (LCTOPC1) directly to the spinal cord in people with traumatic spinal cord injury. The goal is to see if the device is safe and can help replace damaged cells, potentially improving movement and quality of life…
Phase: PHASE1 • Sponsor: Lineage Cell Therapeutics, Inc. • Aim: Disease control
Last updated May 13, 2026 16:03 UTC